WallStreetZenWallStreetZen
Analyst Ranking
Bottom 9%
#3783 out of 4129 analysts
Average Return
-7.79%
Win Rate
33%6 out of 18
Risk vs Reward
Poor
Good

Jacob Johnson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neogenomics IncNEO
+86.62%$27.42$51.17
2020-04-20 -
2021-04-21
Strong Buy
Azenta IncAZTA
+77.54%$66.60$118.24
2020-11-10 -
2021-11-10
Strong Buy
Biolife Solutions IncBLFS
+61.45%$11.75$18.97
2022-05-09 -
2022-12-06
Strong Buy
Avid Bioservices IncCDMO
+57.92%$6.82$10.77
2019-12-09 -
2020-12-10
Strong Buy
Cerus CorpCERS
+20.23%$5.14$6.18
2020-04-15 -
2021-04-16
Strong Buy

Jacob Johnson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Alpha Teknova IncTKNO
3Strong Buy$15.00+229.67%Maintains
4 months ago
Bio Techne CorpTECH
3Strong Buy$480.00+495.02%Maintains
4 months ago
Repligen CorpRGEN
1Strong Buy$275.00+62.60%Maintains
4 months ago
Lifecore Biomedical IncLFCR
1Strong Buy$13.00+61.69%Initiates Coverage On
5 months ago
Ligand Pharmaceuticals IncLGND
1Strong Buy$130.00+91.66%Maintains
7 months ago
Codexis IncCDXS
1Strong Buy$22.00+294.27%Maintains
7 months ago
Biolife Solutions IncBLFS
1Strong Buy$40.00+110.86%Maintains
7 months ago
Charles River Laboratories International IncCRL
1Strong Buy$377.00+78.50%Initiates Coverage On
8 months ago
Avid Bioservices IncCDMO
2Strong Buy$28.00+88.17%Maintains
9 months ago
Neogenomics IncNEO
2Strong Buy$53.00N/AMaintains
a year ago
Maxcyte IncMXCT
1Strong Buy$19.00N/AInitiates Coverage On
a year ago
Azenta IncAZTA
1Strong Buy$69.00N/AUpgrades
2 years ago
West Pharmaceutical Services IncWST
1Hold$300.00N/AInitiates Coverage On
2 years ago
Cerus CorpCERS
1Strong Buy$6.50N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.